Johnson & Johnson COVID Vaccine Heads to FDA for Emergency Use Decision

Johnson & Johnson COVID Vaccine Heads to FDA for Emergency Use Decision

Johnson & Johnson COVID Vaccine Heads to FDA for Emergency Use Decision | Late yesterday Johnson & Johnson submitted a request for an emergency use authorization (EUA) for its COVID-19 candidate. If the EUA is granted by the Food and Drug Administration (FDA), the vaccine will become the third COVID-19 vaccine approved for use in the United States, and the first that requires only one dose…In light of the request, FDA advisors will meet on Feb 26 to weigh emergency use…